Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sun-Young Han

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Toxicological Research|February 11, 2020
c-Jun N-Terminal Kinase Signaling Inhibitors Under DevelopmentSun-Young Han
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Small Molecule Induced FLT3 DegradationSun-Young Han
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
TRK Inhibitors: Tissue-Agnostic Anti-Cancer DrugsSun-Young Han
Journal of Enzyme Inhibition and Medicinal Chemistry|September 18, 2010
A FLT3-inhibitory constituent from the rhizomes of Anemarrhena asphodeloidesSun-Young Han, Young-Won Chin
Expert Opinion on Therapeutic Patents|December 4, 2014
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent reviewYoung-Won Chin, Sun-Young Han
Gerodontology|March 20, 2014
Does denture-wearing status in edentulous South Korean elderly persons affect their nutritional intakes?Sun Young Han, Cheoul Sin Kim
Biomolecules & Therapeutics|August 12, 2025
Small-Molecule-Induced Protein Polymerization: Mechanisms and Therapeutic ImplicationsYoung-Sool Hah, Sun-Young Han
Molecules and Cells|May 10, 2006
JNK regulation of oncogenesisLynn E Heasley, Sun-Young Han
Biomolecules & Therapeutics|August 2, 2024
Gilteritinib Reduces FLT3 Expression in Acute Myeloid Leukemia CellsThị Lam Thái, Sun-Young Han
Expert Opinion on Therapeutic Patents|February 18, 2011
FMS-like tyrosine kinase 3 inhibitors: a patent reviewJongkook Lee, Seung-Mann Paek, Sun-Young Han
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Toxicological Research|February 11, 2020
c-Jun N-Terminal Kinase Signaling Inhibitors Under DevelopmentSun-Young Han
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Small Molecule Induced FLT3 DegradationSun-Young Han
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
TRK Inhibitors: Tissue-Agnostic Anti-Cancer DrugsSun-Young Han
Journal of Enzyme Inhibition and Medicinal Chemistry|September 18, 2010
A FLT3-inhibitory constituent from the rhizomes of Anemarrhena asphodeloidesSun-Young Han, Young-Won Chin
Expert Opinion on Therapeutic Patents|December 4, 2014
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent reviewYoung-Won Chin, Sun-Young Han
Gerodontology|March 20, 2014
Does denture-wearing status in edentulous South Korean elderly persons affect their nutritional intakes?Sun Young Han, Cheoul Sin Kim
Biomolecules & Therapeutics|August 12, 2025
Small-Molecule-Induced Protein Polymerization: Mechanisms and Therapeutic ImplicationsYoung-Sool Hah, Sun-Young Han
Molecules and Cells|May 10, 2006
JNK regulation of oncogenesisLynn E Heasley, Sun-Young Han
Biomolecules & Therapeutics|August 2, 2024
Gilteritinib Reduces FLT3 Expression in Acute Myeloid Leukemia CellsThị Lam Thái, Sun-Young Han
Expert Opinion on Therapeutic Patents|February 18, 2011
FMS-like tyrosine kinase 3 inhibitors: a patent reviewJongkook Lee, Seung-Mann Paek, Sun-Young Han
Pageof 10